Clarus Ventures III GP, L.P.
Insider CIK 1620148 · ANNX 10% owner · GRAY 10% owner · IMGO 10% owner · GRTS · FTSV 10% owner · AVRO 10% owner · PRAX 10% owner · ETTX 10% owner · TALS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMGO Imago BioSciences, Inc. | J Other | 2022-03-30 | 2022-04-01 | 1,000,000 | — | $0 | 2,375,037 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,155,689 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,872,217 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 197,131 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 1,872,217 | — | $0 | 1,872,217 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 1,155,689 | — | $0 | 3,027,906 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 197,131 | — | $0 | 3,225,037 | SEC↗ |
| IMGO Imago BioSciences, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 150,000 | $16.00 | $2.40M | 3,375,037 | SEC↗ |
| PRAX Praxis Precision Medicines | J Other | 2021-05-12 | 2021-05-14 | 2,700,000 | — | $0 | 4,894,109 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 717,160 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 676,774 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 366,918 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 562,891 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 278,707 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 696,767 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 135,334 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 3,586,364 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 1,944,371 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 2,982,874 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 1,476,924 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 3,692,307 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-14 | 26,000,000 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 690,150 | — | $0 | 690,150 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 4,859,812 | — | $0 | 4,859,812 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 701 | $17.00 | $11.9K | 160,044 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 3,507 | $17.00 | $59.6K | 800,353 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 1,902 | $17.00 | $32.3K | 433,917 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 2,917 | $17.00 | $49.6K | 665,676 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 1,444 | $17.00 | $24.5K | 329,598 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 3,611 | $17.00 | $61.4K | 823,997 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-14 | 15,918 | $17.00 | $270.6K | 4,875,730 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 25,296 | — | $0 | 159,343 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 126,499 | — | $0 | 796,846 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 68,582 | — | $0 | 432,015 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 105,213 | — | $0 | 662,759 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 52,094 | — | $0 | 328,154 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 130,236 | — | $0 | 820,386 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 134,047 | — | $0 | 134,047 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 670,347 | — | $0 | 670,347 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 363,433 | — | $0 | 363,433 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 557,546 | — | $0 | 557,546 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-14 | 276,060 | — | $0 | 276,060 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 5,052,852 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 7,375,799 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,410,477 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 559,208 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,941,748 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion deriv | 2020-10-20 | 2020-10-22 | 352,734 | — | $0 | 0 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 3,446,711 | — | $0 | 4,147,645 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 2,361,198 | — | $0 | 6,508,843 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 659,116 | — | $0 | 7,167,959 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 261,318 | — | $0 | 7,429,277 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 907,378 | — | $0 | 907,378 | SEC↗ |
| PRAX Praxis Precision Medicines | C Conversion | 2020-10-20 | 2020-10-22 | 164,832 | — | $0 | 7,594,109 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 1,285,327 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 395,068 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 395,068 | — | $0 | 1,680,395 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,285,327 | — | $0 | 1,285,327 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | P Buy | 2020-09-29 | 2020-10-01 | 250,000 | $16.00 | $4.00M | 1,930,395 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 8,370,685 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 6,148,147 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,109,407 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 5,666,667 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 200,000 | $17.00 | $3.40M | 2,730,635 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 239,433 | — | $0 | 2,530,635 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 697,860 | — | $0 | 2,291,202 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 950,134 | — | $0 | 1,593,342 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 643,208 | — | $0 | 643,208 | SEC↗ |
| AVRO AVROBIO, Inc. | J Other | 2019-05-20 | 2019-05-22 | 1,481,163 | — | $0 | 1,481,162 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion deriv | 2018-10-02 | 2018-10-02 | 668,896 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion deriv | 2018-10-02 | 2018-10-02 | 1,565,216 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | C Conversion | 2018-10-02 | 2018-10-02 | 2,234,112 | — | $0 | 2,567,445 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,702,213 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 8,552,024 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,500,000 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | P Buy | 2018-09-28 | 2018-10-02 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 361,829 | — | $0 | 361,829 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 453,395 | $15.00 | $6.80M | 1,623,405 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 412,583 | — | $0 | 1,170,010 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 323,341 | — | $0 | 685,170 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 3,616,951 | SEC↗ |
| FTSV Forty Seven, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 200,000 | $16.00 | $3.20M | 3,816,951 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 938,489 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 1,694,269 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 9,435,150 | — | $0 | 0 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 2,805,179 | — | $0 | 0 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 2,283,434 | — | $0 | 2,283,434 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 678,891 | — | $0 | 2,962,325 | SEC↗ |